LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 36

Search options

  1. Article ; Online: Sweet Syndrome and Neutrophilic Dermatosis of the Dorsal Hands.

    Hrin, Matthew L / Huang, William W

    Dermatologic clinics

    2023  Volume 42, Issue 2, Page(s) 193–207

    Abstract: Sweet syndrome is a rare cutaneous condition with a broad clinical differential diagnosis. It can be classified into 3 subtypes: classic, malignancy-associated, and drug-induced. There are numerous associated disorders and provoking medications. ... ...

    Abstract Sweet syndrome is a rare cutaneous condition with a broad clinical differential diagnosis. It can be classified into 3 subtypes: classic, malignancy-associated, and drug-induced. There are numerous associated disorders and provoking medications. Uncommonly, it can present as a multiorgan disease and cause significant morbidity. Systemic corticosteroids are the gold standard of treatment and yield rapid improvements in both lesions and symptoms. Nonsteroidal therapies may be effective alternatives, although high-quality comparative data are lacking. Some treatments for Sweet syndrome have paradoxically been implicated in the induction of disease.
    MeSH term(s) Humans ; Sweet Syndrome/diagnosis ; Sweet Syndrome/drug therapy ; Skin/pathology ; Dermatitis/complications ; Adrenal Cortex Hormones/therapeutic use ; Diagnosis, Differential
    Chemical Substances Adrenal Cortex Hormones
    Language English
    Publishing date 2023-09-09
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 82798-8
    ISSN 1558-0520 ; 0733-8635
    ISSN (online) 1558-0520
    ISSN 0733-8635
    DOI 10.1016/j.det.2023.08.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Should systemic corticosteroids be relatively contraindicated in granuloma annulare?

    Oscherwitz, Max E / Hrin, Matthew L / Neuberg, Zachary J / Jorizzo, Joseph L

    Journal of the European Academy of Dermatology and Venereology : JEADV

    2024  

    Language English
    Publishing date 2024-04-05
    Publishing country England
    Document type Letter
    ZDB-ID 1128828-0
    ISSN 1468-3083 ; 0926-9959
    ISSN (online) 1468-3083
    ISSN 0926-9959
    DOI 10.1111/jdv.19990
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Colchicine vs pentoxifylline vs minocycline for generalized granuloma annulare: A retrospective cohort study.

    Greenzaid, Jonathan D / Hrin, Matthew L / Feldman, Steven R / Strowd, Lindsay C

    JAAD international

    2024  Volume 15, Page(s) 134–135

    Language English
    Publishing date 2024-02-28
    Publishing country United States
    Document type Journal Article
    ISSN 2666-3287
    ISSN (online) 2666-3287
    DOI 10.1016/j.jdin.2023.12.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Evaluation of pentoxifylline in the treatment of necrobiosis lipoidica: outcomes in 10 patients.

    Hrin, Matthew L / Oscherwitz, Max / Jorizzo, Joseph L / Feldman, Steven R / Huang, William W

    International journal of dermatology

    2024  Volume 63, Issue 3, Page(s) 390–392

    MeSH term(s) Humans ; Necrobiosis Lipoidica/diagnosis ; Necrobiosis Lipoidica/drug therapy ; Pentoxifylline/therapeutic use ; Diabetes Mellitus, Type 1
    Chemical Substances Pentoxifylline (SD6QCT3TSU)
    Language English
    Publishing date 2024-01-18
    Publishing country England
    Document type Letter
    ZDB-ID 412254-9
    ISSN 1365-4632 ; 0011-9059 ; 1461-1244
    ISSN (online) 1365-4632
    ISSN 0011-9059 ; 1461-1244
    DOI 10.1111/ijd.17037
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Confidence in Biosimilar Drugs is Not Much Improved by Framing Them as the "Gold" Alternative Treatment Option to Bio-originators.

    Hrin, Matthew L / Feldman, Steven R

    Dermatology and therapy

    2021  Volume 11, Issue 4, Page(s) 1409–1413

    Abstract: Introduction: Biosimilar drugs have promising potential to provide substantial health, financial, and access benefits to patients and the entire healthcare system. However, skepticism remains a hurdle to their incorporation into clinical practice.: ... ...

    Abstract Introduction: Biosimilar drugs have promising potential to provide substantial health, financial, and access benefits to patients and the entire healthcare system. However, skepticism remains a hurdle to their incorporation into clinical practice.
    Methods: In this study, we evaluated how confidence in biosimilar drugs is impacted by framing them as the "gold" alternative treatment option to bio-originators. An online survey was administered to subjects with self-reported diagnoses of psoriasis. All participants were provided a hypothetical scenario that their insurance would not cover the costs of a bio-originator agent. They were randomized to one of two groups which both received three alternative treatment options; group one was presented a biosimilar without framing and group two was presented a biosimilar framed as the "gold" alternative treatment option.
    Results: More respondents in the "gold" framing intervention group than in the control group were confident in the biosimilar (30.3 vs. 25.8%); however, the differences were small and not statistically significantly different (p = 0.266).
    Conclusion: It does not appear that framing biosimilar drugs as the "gold" alternative treatment option to their reference products has a large impact on confidence in them.
    Language English
    Publishing date 2021-05-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2680284-3
    ISSN 2190-9172 ; 2193-8210
    ISSN (online) 2190-9172
    ISSN 2193-8210
    DOI 10.1007/s13555-021-00542-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Mycophenolate Mofetil for Genital and Extragenital Lichen Sclerosus Et Atrophicus.

    Patel, Palak V / Hrin, Matthew L / Feldman, Steven R / Pichardo, Rita

    Journal of cutaneous medicine and surgery

    2023  Volume 27, Issue 6, Page(s) 654–655

    MeSH term(s) Humans ; Lichen Sclerosus et Atrophicus/drug therapy ; Mycophenolic Acid/therapeutic use ; Skin ; Genitalia
    Chemical Substances Mycophenolic Acid (HU9DX48N0T)
    Language English
    Publishing date 2023-11-09
    Publishing country United States
    Document type Letter
    ZDB-ID 1361720-5
    ISSN 1615-7109 ; 1203-4754
    ISSN (online) 1615-7109
    ISSN 1203-4754
    DOI 10.1177/12034754231211327
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Methotrexate and acitretin in pityriasis rubra pilaris: A retrospective cohort study.

    Greenzaid, Jonathan D / Hrin, Matthew L / Feldman, Steven R / Strowd, Lindsay C

    Journal of the American Academy of Dermatology

    2023  Volume 90, Issue 3, Page(s) 652–654

    MeSH term(s) Humans ; Acitretin/therapeutic use ; Methotrexate/therapeutic use ; Pityriasis Rubra Pilaris/drug therapy ; Retrospective Studies ; Skin
    Chemical Substances Acitretin (LCH760E9T7) ; Methotrexate (YL5FZ2Y5U1)
    Language English
    Publishing date 2023-11-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 603641-7
    ISSN 1097-6787 ; 0190-9622
    ISSN (online) 1097-6787
    ISSN 0190-9622
    DOI 10.1016/j.jaad.2023.11.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Receptivity to misinformation is associated with a preference for complementary alternative medicine for atopic dermatitis.

    Pham, Quan / Hrin, Matthew L / Ghamrawi, Rima I / Fleischer, Alan B / Taylor, Sarah L / Feldman, Steven R

    International journal of dermatology

    2024  

    Language English
    Publishing date 2024-04-04
    Publishing country England
    Document type Letter
    ZDB-ID 412254-9
    ISSN 1365-4632 ; 0011-9059 ; 1461-1244
    ISSN (online) 1365-4632
    ISSN 0011-9059 ; 1461-1244
    DOI 10.1111/ijd.17143
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Reassurance Techniques Do Not Significantly Impact Confidence in Biosimilars for Psoriasis: A Survey of a Convenience Sample of Individuals with Self-Identified Psoriasis.

    Hrin, Matthew L / Bray, Jeremy K / Feldman, Steven R

    Dermatology and therapy

    2022  Volume 12, Issue 9, Page(s) 2173–2180

    Abstract: Introduction: Biosimilars are underutilized, and negative perceptions may hinder their acceptance by patients. Psychologic interventions have not been extensively studied in the context of alleviating biosimilar hesitancy. The objective of this study ... ...

    Abstract Introduction: Biosimilars are underutilized, and negative perceptions may hinder their acceptance by patients. Psychologic interventions have not been extensively studied in the context of alleviating biosimilar hesitancy. The objective of this study was to assess the effectiveness of psychologic interventions on biosimilar confidence.
    Methods: Following institutional review board (IRB) approval, 1285 subjects with self-reported psoriasis were recruited using Amazon Mechanical Turk, an online crowdsourcing platform. Participants were randomized to one of ten groups. Group A started with a hypothetical bio-originator; group B started with a hypothetical biosimilar. The remaining groups were provided a hypothetical scenario in which they were switching to a biosimilar after achieving great results with a bio-originator, and were randomized to receive either no reassurance (group C) or one of the following psychologic interventions: reassurance of comparable effectiveness (group D), an illustration implying comparable effectiveness (group E), anecdote of great results obtained in "other psoriasis patients" (group F), anecdote of great results obtained in another psoriasis patient "a lot like you" (group G), reassurance of the rigorous evaluation process to gain Food and Drug Administration (FDA) approval (group H), engagement in a task designed to facilitate recognition of biosimilars' comparability through answering multiple choice (group I) or free response questions (group J). Confidence levels were assessed using six-point Likert scales and analyzed using one-way analysis of variance (ANOVA) and two-group t-tests.
    Results: While no statistically significant differences were detected, illustrations implying comparability (mean 4.19), explanations of the rigorous process to gain FDA approval (mean 4.21), testimonials of treatment success in another psoriasis patient "a lot like you" (mean 4.07) and "other psoriasis patients" (mean 4.01), and engagement with multiple choice (mean 4.02) and free response answers (mean 4.08) improved biosimilar confidence compared with the biosimilar switch control group (mean 3.96).
    Conclusion: Identifying highly impactful methods of improving biosimilar confidence remains a challenge.
    Language English
    Publishing date 2022-07-28
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2680284-3
    ISSN 2190-9172 ; 2193-8210
    ISSN (online) 2190-9172
    ISSN 2193-8210
    DOI 10.1007/s13555-022-00781-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Colchicine for Erythema Nodosum: A Retrospective Case Series.

    Hrin, Matthew L / Patel, Palak V / Jorizzo, Joseph L / Feldman, Steven R / Huang, William W

    Journal of cutaneous medicine and surgery

    2023  Volume 27, Issue 6, Page(s) 662–663

    MeSH term(s) Humans ; Erythema Nodosum/drug therapy ; Colchicine/therapeutic use ; Retrospective Studies
    Chemical Substances Colchicine (SML2Y3J35T)
    Language English
    Publishing date 2023-10-12
    Publishing country United States
    Document type Letter
    ZDB-ID 1361720-5
    ISSN 1615-7109 ; 1203-4754
    ISSN (online) 1615-7109
    ISSN 1203-4754
    DOI 10.1177/12034754231204861
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top